[ad_1]
U.S. indices slid amid an AI-led rotation and macro uncertainty: S&P 500 and Nasdaq pulled back, Nasdaq leading losses as tech and AI darlings retraced. The Dow lagged but held up better; volatility spiked and defensive sectors outperformed. Key catalysts: OpenAI/AWS deal, Palantir volatility, Supreme Court tariff risk and the ongoing government shutdown.
The U.S. government shutdown has hit its longest mark, dragging critical services and budget talks into crisis. SNAP benefits are being cut or partially funded, forcing states and charities to scramble as travel and federal operations strain.
38B – Value in dollars of OpenAI’s seven‑year cloud deal with Amazon Web Services.
OpenAI sealed a multiyear, multibillion-dollar compute deal with Amazon Web Services, reshaping the AI cloud landscape. The pact marks a major shift in cloud supplier dynamics and signals huge long-term spending on AI infrastructure.
Microsoft is locking up AI capacity through major cloud and data-center deals and secured permissions to export top Nvidia chips. Those moves expand Microsoft’s global AI footprint and raise export-control and geopolitical questions.
Idexx Labs Jumps 15% After Q3 Beat
Idexx Laboratories beat Q3 forecasts and raised guidance, sending shares higher as vet diagnostics demand strengthens—positive signal for recurring-revenue diagnostics names.
More on 247wallst.com
Nvidia’s rally and analyst re-ratings keep the chip maker at the center of markets even as valuations soar. Price-target hikes and record market caps underline investor conviction — and the fragility of AI-led rallies.
Palantir delivered strong revenue growth but the stock swung sharply after earnings, highlighting valuation sensitivity in AI names. Markets punished the after-hours move, reflecting investor caution after lofty expectations.
Zoetis Slashes 2025 Sales Forecast… Stock Plunges
Zoetis cut its full‑year sales outlook after weak demand for animal treatments, pushing the stock sharply lower and signaling softening trends in pet and livestock medicine spending.
More on investors.com
Crypto markets soured in November as large liquidations and heavy selling pushed major tokens sharply lower. The liquidation wave wiped more than $1bn from leveraged positions and intensified a risk-off rotation.
DeFi platform Stream Finance halted withdrawals after a large disclosed fund loss, prompting investigations and legal scrutiny. Analysts warn the hit could propagate through protocols with cross-protocol exposures.
Partial SNAP funding will be released from contingency reserves while the Supreme Court reviews presidential tariff authority—expect short‑term relief for benefits but heightened trade-policy uncertainty if tariffs are upheld or limited.
Sarepta suffered a major clinical setback with two failed confirmatory tests, sending the biotech’s share price tumbling. The failure raises doubts about the company’s gene-therapy outlook and near-term revenue trajectory.
A fierce bidding war for obesity-drug startup Metsera intensified as Novo Nordisk and Pfizer sweetened offers. The tussle highlights strategic urgency among big pharma to dominate the weight-loss drug market.
You should assume they’re here to stay.
— Scott Bessent, U.S. Treasury Secretary
Kimberly‑Clark agreed to buy Kenvue, owner of Tylenol, in a multibillion-dollar deal that reunites major consumer-health brands. The takeover tests whether scale can absorb regulatory and reputational shocks tied to product controversies.
The Supreme Court prepares to hear arguments on the legality of presidential tariff powers, a case that could reshape U.S. trade policy. The hearing has political and market implications as tariffs fund a new revenue stream.
Wall Street chiefs warned a material market correction is possible, prompting futures and risk-sensitive sectors to sell off. The warnings reinforced volatility and a rotation away from momentum-driven AI names.
Layoffs and cost-cutting continue across tech and corporate America, with AI often cited as a catalyst and scapegoat. Workers are turning to new gig roles, including paid AI training tasks, reshaping the labor market.
Starbucks agreed to sell a majority stake in its China operations to Boyu Capital, a move to stabilize growth amid local competition. The deal marks a strategic pivot to local partners for major US consumer brands.
Travel systems are fraying as the shutdown forces staffing shortfalls and operational strains, with smaller carriers collapsing and airports warning of holiday chaos. Travel firms urge Congress to reopen government before Thanksgiving.
Oil majors and national champions report mixed earnings as prices and demand dynamics shift. Producers are rebalancing portfolios and preparing asset sales while profits show the strain of lower prices.
Beijing ramps incentives for domestic AI and data-center builds, cutting power costs to spur local chip adoption. The moves aim to accelerate self-sufficiency but risk heightening global supply-chain tensions in semiconductors.
Fresh strikes and drone campaigns are hitting energy and military infrastructure, keeping geopolitical risk elevated and markets jittery. The incidents underscore how conflict zones can rapidly affect commodity and logistics flows.
[ad_2]